SPDR S&P Biotech ETF (XBI)
$73.465
-0.53 (-0.71%)
Rating:
Recommendation:
-
Symbol | XBI |
---|---|
Price | $73.465 |
Beta | 0.000 |
Volume Avg. | 6.44M |
Market Cap | - |
Shares () | - |
52 Week Range | 71.59-92.6 |
1y Target Est | - |
DCF Unlevered | XBI DCF -> | |
---|---|---|
DCF Levered | XBI LDCF -> | |
ROE | - | |
ROA | - | |
Operating Margin | - | |
Debt / Equity | - | |
P/E | - | |
P/B | - |
Latest XBI news
About
Download (Excel)In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").